Detection of HIV-1 infection in blood donors during the immunological window period using the nucleic acid-amplification technology

Transfusion Medicine

Volumn 17, Issue 3, 2007, Pages 200-204

  Scuracchio, P S P ^a,c   Poli, M C C ^a   Lemos, M M M ^a   Oliveira Filho, A G ^a   Salles, N A ^a   Chamone, D A F ^a   Magri, M ^b   Cavalcante, N J F ^b   Collela, R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STD/AIDS Ref and Training Center   (Brazil)

^c Banco de Sangue de São Paulo ^*  (Brazil)

Author keywords

Blood donors; HIV 1 NAT; Immunological window; Individual NAT; Residual risk; Seroconversion

Indexed keywords

ANTIGEN P24;

ANTIGEN DETECTION; ARTICLE; BLOOD DONOR; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LAW; MALE; NUCLEIC ACID AMPLIFICATION; POLYMERASE CHAIN REACTION; SCREENING; SERODIAGNOSIS; VIRUS TRANSMISSION; WESTERN BLOTTING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD DONORS; CONFIDENCE INTERVALS; DNA, VIRAL; FEMALE; HEPATITIS C; HIV-1; HUMANS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PATIENT SELECTION; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 34250157403     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2007.00748.x     Document Type: Article

References (17)

1. Allain, J.-P. (2003) Transfusion risks of yesterday and of today. Transfusion Clinique et Biologique, 10, 1 5.
2. Alvarez, M., Oyonarte, S., Rodriguez, P.M. Hernandez, J.M 2002) Estimated risk for transfusion-transmitted viral infections in Spain. Transfusion, 42, 994 998.
3. Barreto, C.C., Sabino, E.C., Gonçalez, T.T. et al 2005) Prevalence, incidence and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil. Transfusion, 45, 1709 1714.
4. Brasil. Agência Nacional de Vigilância Sanitária (ANVISA). Portaria n° 112, de 29 de Janeiro de 2004. Dispõe sobre a implantação no âmbito da Hemorrede Nacional da realização dos testes de amplificação e detecção de ácido nucléico (NAT), para HIV e HCV. Diário Oficial da União, Brasília, DF, 30 de Janeiro de 2004. Seção 1, p. 71 72.
5. Busch, M.P., Glynn, S.A., Stramer, S.L., Strong, D.M., Caglioti, S., Wright, D.J., Pappalardo, B. Kleinman, S.H 2005) A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donations. Transfusion, 45, 254 264.
6. Flanagan, P. Snape, T 1998) Nucleic acid technology (NAT) testing and the transfusion service: a rationale the implementation of minipool testing. Transfusion Medicine, 8, 9 13.
7. Gonzales, M., Règine, V., Piccinini, V., Vulcano, F., Giampaolo, A. Hassan, H.J 2005) Residual risk of transmission-transmitted human immunodeficiency virus, hepatitis C virus and hepatitis B virus infections in Italy. Transfusion, 45, 1670 1675.
8. Gonzalez, T.T., Sabino, E.C., Murphy, E.L., Chen, S., Chamone, D.A.F. McFarlands, W 2006) Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil. Vox Sanguinis, 90, 170 176.
9. Heyns Adu, P., Benjamin, R.J., Swanevelder, J.P.R., Laycock, M.E., Pappalardo, B.L., Crookes, R.L., Wright, D.J. Busch, M.P 2006) Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa. Journal of the American Medical Association, 295, 519 526.
10. Jarvis, L.M., Dow, B.C., Cleland, A. et al 2005) Detection of HCV and HIV-1 antibody negative infections in Scottish and Northern Ireland blood donations by nucleic acid amplification testing. Vox Sanguinis, 89, 128 134.
11. Levi, J.E., Wendel, S., Takaoka, D.T., Silva, I.C., Fachini, R., Ghaname, J., Gioachini, R.J. Brandão, J.B 2003) Experiência no uso de biologia molecular na triagem de doadores de angue no Brasil. In: 26o Congresso da SBHH-HEMO, 2003, São Paulo/S.P. Revista Brasileira de Hematologia e Hemoterapia, 25, 240.
12. Polite, M.B., Santos, M.J., Cabral, S.P., Takaya, Y.A., Tomaz, K.F., Kutner, J.M. Ferreira, O.C., Jr. 2003) Two years of individual donor screening for HCV nucleic acid testing. In: 26o Congresso da SBHH-HEMO, 2003, São Paulo/S.P. Revista Brasileira de Hematologia e Hemoterapia, 25, 239.
13. Roth, W.K., Weber, M., Buhr, S., Drosten, C., Weichert, W., Sireis, W., Hedges, D. Seifried, E 2002) Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in Central Europe. Transfusion, 42, 862 868.
14. Sabino, E.C., Salles, N.A., Sáez-Alquezar, A., Santos, G.R., Chamone, D.F. Busch, M.P 1999) Estimated risk of transfusion-transmitted HIV infection in São Paulo, Brazil. Transfusion, 39, 1152 1153.
15. Seed, C.R., Kiely, P. Keller, A.J 2005) Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus. Internal Medicine Journal, 35, 592 598.
16. Stramer, S.L., Glynn, S.A., Kleinman, S.H., Strong, D.M., Caglioti, S., Wright, D.J., Dodd, R.Y. Busch, M.P 2004) Detection of HIV-1 and HCV infections among antibody-negative blood donors by acid-amplification testing. New England Journal of Medicine, 351, 760 768.
17. Wendel, S., Fachini, R.M., Levi, J.E., Ghaname, J.N., Mendonça, M.C., Almeida Neto, C., Braga, M.C. Di Pietro, A.E 2002) A single window-period donation detected by human immunodeficiency virus p24 antigen after 5 years of routine screening in a group of Brazilian blood banks. Vox Sanguinis, 83, 309 312.